Israeli-developed electronic fencing and PIDS technology to address critical infrastructure needs and expand homeland security portfolio in Mexico Tel Aviv, Israel, March 11, 2026 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace expanding into the global homeland security sector through advanced artificial intelligence (“AI”) – driven solutions, today announced that its wholly-owned subsidiary, KeepZone AI Inc. (“KeepZone”), has entered into a reseller agreement (the “Agreement”) with D-Fence Ltd. (“D-Fence”), a leading Israeli supplier of Perimeter Intrusion Detection Systems (“PIDS”), products and solutions. Under the terms of the Agreement, KeepZone was appointed as a reseller for D-Fence’s custom-made PIDS...

NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) — Vornado Realty Trust (NYSE: VNO) and LeFrak today announced an agreement with Le Colonial to open a new restaurant at 50 West 57th Street, marking the acclaimed French Vietnamese concept’s highly anticipated return to Manhattan. This new location is expected to open summer 2027. Under a 15-year lease, Le Colonial will create a new dining destination across 9,600 square feet located between Fifth and Sixth Avenues in the heart of Midtown Manhattan. The restaurant will feature 215 seats, offering indoor and outdoor seating, a full bar and lounge, and private dining. In addition, Le Colonial signed a companion office lease to house its New York City offices on the building’s entire seventh floor. Founded in 1993 by celebrated restaurateur Rick Wahlstedt and partners, Le Colonial introduced...

Directors Michael A. Miles, Jr. and Joshua A. Lutzker announce they will not stand for reelection at the Company’s 2026 Annual Meeting CHICAGO, March 11, 2026 (GLOBE NEWSWIRE) — Portillo’s (NASDAQ: PTLO), the fast-casual restaurant concept known for its menu of Chicago-style favorites, today announced a leadership transition within its Board of Directors. The Board has appointed Eugene I. Lee, Jr., a respected veteran of the restaurant industry and award-winning foodservice leader, as Chairman of the Board, effective immediately. Lee succeeds Michael A. Miles, Jr., who will retire after leading the Company’s Board of Directors since 2014, where he helped transition Portillo’s from a founder-led company to a public company. “It’s an honor to step into the role of Chairman at this pivotal time. Portillo’s is an iconic brand with a...

AI-enabled day and thermal imaging payload camera designed for lightweight defense UAV platforms and mission-critical intelligence gathering Rehovot, Israel, March 11, 2026 (GLOBE NEWSWIRE) — Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a global leader in artificial intelligence (“AI”)-based edge video processing technology, today announced the development of a new advanced drone gimbal camera designed to support intelligence gathering, surveillance, and situational awareness missions for unmanned aerial platforms. The new camera, once developed, will integrate a 4K day camera and a thermal imaging sensor, supporting real-time video streaming and advanced AI-powered analytics directly at the edge. Designed with a strong focus on miniaturization and low weight, the camera is intended to meet the strict...

Ongoing activities, including new engagement to relist on Nasdaq, new board member, continued advancement of Phase 1 trial into MDS patients, strategic engagement, and continued support from lead investor, underscore the Company’s operational momentum SOUTH SAN FRANCISCO, Calif., March 11, 2026 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc. (OTCQB: CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanism, provides an update through the letter to stockholders and stakeholders from CEO Chris Ehrlich: To our stockholders and stakeholders: Following our recent Form 8-K filing confirming receipt of convertible debt funding to support current operations, we believe it is an appropriate time to provide an update on CERo Therapeutics’ operational and scientific...

Expands institutional footprint with potential penetration of more than ~ 60% of the U.S. market, while expanding reach across EMS providers and rehabilitation centers U.S. naloxone market totals $141M with 9.4 million prescription units annually, represents significant commercial opportunity for REZENOPY™ COMMACK, NY, March 11, 2026 (GLOBE NEWSWIRE) — SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through the development, commercialization, and distribution of novel specialty products that address unmet market needs, today announced that it has formalized multiple commercial Group Purchasing Organization (GPO) agreements for REZENOPYTM (naloxone HCl) Nasal Spray 10 mg, providing...

ROCKVILLE, Md. and SUZHOU, China, March 11, 2026 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (Ascentage Pharma) (NASDAQ: AAPG; HKEX: 6855) (referred herein as “Ascentage Pharma,” the “Company,” “we,” “us” or “our”), a global, commercial stage, integrated biopharmaceutical company engaged in discovering, developing and commercializing novel, differentiated therapies to address unmet medical needs in cancer, today reported it will release its full year 2025 unaudited results and provide business updates at 7:00 pm Eastern Daylight Time (EDT) on March 25, 2026 / 7:00 am Hong Kong Time (HKT) on March 26, 2026. Analysts and investors are invited to join the investor webcast with Q&A, conducted by the Company’s management team. Ascentage Pharma will host a Chinese (Mandarin) language investor webcast at 10:00 pm EDT on...

Supermicro’s AI-optimized compute platforms supports BlockchAIn’s U.S. data center development pipeline SCOTTSDALE, AZ, March 11, 2026 (GLOBE NEWSWIRE) — Signing Day Sports, Inc. (“Signing Day Sports”, “SGN” or the “Company”) (NYSE American: SGN), in connection with the Company’s previously announced proposed business combination with One Blockchain LLC (“BlockchAIn LLC”), today announced that BlockchAIn LLC is collaborating with Super Micro Computer, Inc. (“Supermicro”) (NASDAQ: SMCI), a publicly traded technology company based in San Jose, California that provides total IT solutions for enterprise, cloud, AI, and 5G/Edge infrastructure, including servers, AI systems, storage, networking, software, and support services. Working together, BlockchAIn LLC intends to deliver an end-to-end AI infrastructure platform by integrating...

HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 11, 2026 (GLOBE NEWSWIRE) — Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced it has received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) confirming that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (“Rule”). To regain compliance with the Rule, the Company’s common stock was required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive business days, which the Company satisfied on March 9, 2026. Therefore, the Nasdaq Listing Qualifications Staff considers the prior bid price deficiency matter...

Cincinnati Children’s Applied Gene and Cell Therapy Center selected to conduct tech transfer, development and IND-enabling manufacturing All activities other than long-term stability testing planned to be complete in Q3 2026 to support potential IND filing in Q4 2026 Selection of tech transfer partner follows Tempest’s recent announcement of positive interim data from the ongoing REDEEM-1 Phase 1/2a trial of TPST-2003, including 100% CR in all six efficacy evaluable patients, and accelerated development timelineBRISBANE, Calif., March 11, 2026 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage biotechnology company developing a pipeline of advanced CAR-T cell therapy product candidates to treat cancer, today announced the selection of Cincinnati Children’s Applied Gene and Cell Therapy...